Provention Bio, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 30.173 million compared to USD 22.796 million a year ago. Net loss was USD 29.142 million compared to USD 22.122 million a year ago. Basic loss per share from continuing operations was USD 0.46 compared to USD 0.45 a year ago. For the half year, operating loss was USD 62.641 million compared to USD 35.661 million a year ago. Net loss was USD 61.582 million compared to USD 34.704 million a year ago. Basic loss per share from continuing operations was USD 0.98 compared to USD 0.72 a year ago.